Agfa-Gevaert's Preliminary 2010 Results in Line with its Guidance

Agfa HealthCareThe Agfa-Gevaert Group's full year revenue amounted to 2,948 million Euro, an increase of 7.0 percent (3.2 percent excluding currency effects) compared to 2009. About half of this growth is related to Agfa Graphics' joint venture in China and the Pitman acquisition.

The Agfa-Gevaert Group's total 2010 EBIT is expected to be approximately 266 million Euro (9.0 percent of revenue), versus 182 million Euro (6.6 percent of revenue) in 2009.

The full year net result is expected to be above 100 million Euro, versus 6 million Euro in 2009.

At year end, net debt stood at 161 million Euro, compared to 445 million Euro at the end of 2009.

In spite of the uncertainties that the graphic markets faced in the fourth quarter, particularly in Europe, the revenue of the Agfa Graphics business group amounted to 1,565 million Euro. Excluding currency effects, the increase would amount to 12.2 percent.

Agfa Graphics' EBIT is expected to be about 134 million Euro (8.6 percent of revenue), compared to 63 million Euro in 2009 (4.7 percent of revenue).

Agfa HealthCare's full year revenue is almost stable at 1,180 million Euro. Excluding currency effects, a decrease of 3.3 percent would have been posted. Agfa HealthCare expects that the growth of the IT division will start to compensate for the revenue decline in the traditional business in the course of the second half of 2011.

Agfa HealthCare's EBIT is expected to amount to approximately 126 million Euro (10.7 percent of revenue), versus 116 million Euro in 2009 (9.8 percent of revenue).

The revenue of the smaller Agfa Specialty Products business group amounted to 203 million Euro, a decrease by 14.0 percent (15.4 percent excluding currency effects), mainly because of the shift of part of the film business to Agfa Graphics and the market-driven decline for some of the Classic Film products.

Agfa Specialty Products' EBIT is expected to amount to approximately 8 million Euro (3.9 percent of revenue), versus 13 million Euro in 2009 (5.5 percent of revenue).

Agfa-Gevaert's CEO Christian Reinaudo commented: "Both in terms of top line and in terms of EBIT, our 2010 results are in line with the outlook we gave in August. Driven by Agfa Graphics, we posted a revenue increase close to 200 million Euro. Both Agfa Graphics and Agfa HealthCare met their EBIT targets. So far, we only saw limited effects of the high raw material costs. The raw material related impact on the margins is expected to be more substantial as from the first quarter of this year. The effects of the recently announced price increases for our film products are expected to become more visible in the course of the second half of the year. In spite of the adverse situation on the raw material markets, we maintain - for the medium term - our average EBIT guidance."

Agfa-Gevaert will disclose its complete and fully audited 2010 results on March 25.

Related news articles:

About Agfa-Gevaert
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials).

Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...